Meridian Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$4.75M Buy
10,166
+4,844
+91% +$2.27M 1.3% 27
2025
Q1
$2.65M Sell
5,322
-26
-0.5% -$12.9K 0.82% 35
2024
Q4
$2.78M Sell
5,348
-355
-6% -$185K 0.73% 34
2024
Q3
$3.53M Buy
5,703
+93
+2% +$57.5K 0.9% 31
2024
Q2
$3.1M Sell
5,610
-61
-1% -$33.7K 0.85% 33
2024
Q1
$3.3M Buy
5,671
+86
+2% +$50K 0.9% 30
2023
Q4
$3.08M Sell
5,585
-49
-0.9% -$27K 0.87% 30
2023
Q3
$2.85M Buy
5,634
+23
+0.4% +$11.6K 0.93% 26
2023
Q2
$2.93M Sell
5,611
-99
-2% -$51.7K 0.92% 29
2023
Q1
$3.29M Sell
5,710
-169
-3% -$97.4K 1.08% 27
2022
Q4
$3.24M Buy
5,879
+23
+0.4% +$12.7K 1.18% 25
2022
Q3
$2.97M Buy
5,856
+152
+3% +$77.1K 1.19% 27
2022
Q2
$3.1M Sell
5,704
-406
-7% -$221K 1.2% 25
2022
Q1
$3.61M Sell
6,110
-68
-1% -$40.2K 1.14% 25
2021
Q4
$4.12M Buy
6,178
+40
+0.7% +$26.7K 1.19% 25
2021
Q3
$3.51M Sell
6,138
-187
-3% -$107K 1.08% 28
2021
Q2
$3.19M Sell
6,325
-2,841
-31% -$1.43M 0.94% 34
2021
Q1
$4.18M Buy
9,166
+121
+1% +$55.2K 1.3% 25
2020
Q4
$4.21M Sell
9,045
-55
-0.6% -$25.6K 1.35% 24
2020
Q3
$4.02M Sell
9,100
-68
-0.7% -$30K 1.49% 17
2020
Q2
$3.32M Sell
9,168
-2,165
-19% -$784K 1.36% 20
2020
Q1
$3.21M Buy
11,333
+58
+0.5% +$16.4K 1.55% 16
2019
Q4
$3.66M Sell
11,275
-18
-0.2% -$5.85K 1.47% 18
2019
Q3
$3.29M Sell
11,293
-4
-0% -$1.17K 1.47% 19
2019
Q2
$3.32M Buy
11,297
+557
+5% +$164K 1.47% 19
2019
Q1
$2.94M Sell
10,740
-20
-0.2% -$5.48K 1.46% 18
2018
Q4
$2.41M Hold
10,760
1.23% 22
2018
Q3
$2.63M Buy
10,760
+15
+0.1% +$3.66K 1.14% 26
2018
Q2
$2.23M Buy
10,745
+120
+1% +$24.9K 1.03% 30
2018
Q1
$2.19M Buy
+10,625
New +$2.19M 1.01% 30